BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37611180)

  • 1. Provision of ambrisentan from a health-system specialty pharmacy affiliated with a pulmonary hypertension Center of Comprehensive Care.
    Gutenschwager DW; Patel A; Soyad AT; Patel S; Szandzik EG; Kelly B; Smith ZR
    Am J Health Syst Pharm; 2024 Jan; 81(2):66-73. PubMed ID: 37611180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-system specialty pharmacy role and outcomes: A review of current literature.
    Zuckerman AD; Whelchel K; Kozlicki M; Simonyan AR; Donovan JL; Gazda NP; Mourani J; Smith AM; Young L; Ortega M; Kelley TN
    Am J Health Syst Pharm; 2022 Oct; 79(21):1906-1918. PubMed ID: 35916907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to oral oncolytics filled through an internal health-system specialty pharmacy compared with external specialty pharmacies.
    Academia EC; Mejías-De Jesús CM; Stevens JS; Jia LY; Yankama T; Patel C; Lee J
    J Manag Care Spec Pharm; 2021 Oct; 27(10):1438-1446. PubMed ID: 34595953
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of time to treatment initiation of specialty medications between an integrated health system specialty pharmacy and external specialty pharmacies.
    Russell M; McCoy H; Platt T; Zeltner M; Rhudy C
    J Manag Care Spec Pharm; 2024 Apr; 30(4):352-362. PubMed ID: 38555622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the removal of the monthly liver function test requirement for ambrisentan.
    Durst LA; Carlsen J; Kuchinski M; Harner L; Neves D; Harris SJ; Traiger GL
    Am Health Drug Benefits; 2012 Mar; 5(2):94-101. PubMed ID: 24991314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2022 ASHP Survey of Health-System Specialty Pharmacy Practice: Clinical Services.
    Zuckerman AD; Mourani J; Smith A; Ortega M; Donovan JL; Gazda NP; Tong K; Simonson D; Kelley T; DeClercq J; Choi L; Pierce G
    Am J Health Syst Pharm; 2023 Jun; 80(13):827-841. PubMed ID: 36999452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of rates of adherence to oral chemotherapy medications filled through an internal health-system specialty pharmacy vs external specialty pharmacies.
    McCabe CC; Barbee MS; Watson ML; Billmeyer A; Lee CE; Rupji M; Chen Z; Haumschild R; El-Rayes B
    Am J Health Syst Pharm; 2020 Jul; 77(14):1118-1127. PubMed ID: 32537656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Droxidopa management by an integrated health-system specialty pharmacy team.
    Livezey SN; Shah NB; DeClercq J; Keefe J; Choi L; Shibao C; Zuckerman AD
    J Am Pharm Assoc (2003); 2022; 62(6):1904-1911. PubMed ID: 35787811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development, implementation, and evaluation of a health outcomes and research program at an integrated health-system specialty pharmacy.
    Zuckerman AD; Shah NB; Peter ME; Jolly JA; Kelley TN
    Am J Health Syst Pharm; 2021 May; 78(11):972-981. PubMed ID: 33693451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inclusion in limited distribution drug network reduces time to dalfampridine access in patients with multiple sclerosis at a health-system specialty pharmacy.
    Peter ME; Markley B; DeClercq J; Choi L; Givens G; Zuckerman AD; Banks A
    J Manag Care Spec Pharm; 2021 Feb; 27(2):256-262. PubMed ID: 33506731
    [No Abstract]   [Full Text] [Related]  

  • 11. Addressing the Challenges of Novel Oncology and Hematology Treatments Across Sites of Care: Specialty Pharmacy Solutions.
    Wyatt H; Zuckerman AD; Hughes ME; Arnall J; Miller R
    J Oncol Pharm Pract; 2022 Apr; 28(3):627-634. PubMed ID: 35037778
    [No Abstract]   [Full Text] [Related]  

  • 12. Low rates of primary medication nonadherence in patients prescribed oral oncology agents across health system specialty pharmacies.
    Zuckerman A; Crumb J; Kandah HM; Platt T; Duckworth D; Lo K; Mitchell D; Diamantides E; Streck CM; DeClercq J; Choi L; Patel R
    J Manag Care Spec Pharm; 2023 Jul; 29(7):740-748. PubMed ID: 37404071
    [No Abstract]   [Full Text] [Related]  

  • 13. High rates of medication adherence in patients with pulmonary arterial hypertension: An integrated specialty pharmacy approach.
    Shah NB; Mitchell RE; Proctor ST; Choi L; DeClercq J; Jolly JA; Hemnes AR; Zuckerman AD
    PLoS One; 2019; 14(6):e0217798. PubMed ID: 31170217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of an integrated pharmacist collaborative care model in specialty disease state clinics.
    Stroedecke N; Lee J; Stutsky M; Boothe K; Tong K; Luon S; Sawant V; Renauer M
    Am J Health Syst Pharm; 2022 Nov; 79(22):2047-2052. PubMed ID: 35913890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of prior authorization success and timeliness at a community-based specialty care pharmacy.
    Hecht B; Frye C; Holland W; Holland CR; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2021; 61(4S):S173-S177. PubMed ID: 33618986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the impact of a health-system specialty pharmacy patient management program on achieving predefined clinical outcome measures.
    O'Reilly E; Foushee S; Nolan L; Maier C; McPheeters C
    Am J Health Syst Pharm; 2024 Apr; 81(9):e226-e233. PubMed ID: 38169475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancing Patient Care Through Specialty Pharmacy Services in an Academic Health System.
    Bagwell A; Kelley T; Carver A; Lee JB; Newman B
    J Manag Care Spec Pharm; 2017 Aug; 23(8):815-820. PubMed ID: 28737983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving transitions of care for critically ill adult patients on pulmonary arterial hypertension medications.
    Martirosov AL; Smith ZR; Hencken L; MacDonald NC; Griebe K; Fantuz P; Grafton G; Hegab S; Ismail R; Jackson B; Kelly B; Miller M; Awdish R
    Am J Health Syst Pharm; 2020 Jun; 77(12):958-965. PubMed ID: 32495842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheumatoid arthritis medication adherence in a health system specialty pharmacy.
    Berger N; Peter M; DeClercq J; Choi L; Zuckerman AD
    Am J Manag Care; 2020 Dec; 26(12):e380-e387. PubMed ID: 33315331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing Access to Hepatitis C Virus Medications: A Program Model Using Patient Navigators and Specialty Pharmacy to Obtain Prior Authorization Approval.
    Vu TM; Toribio W; Riazi F; Ciprian G; Gibbs N; Giardina M; Camacho JA; Parrella K; Cambe J; Amory C; Chasan R; Sigel KM; Weiss JJ
    J Manag Care Spec Pharm; 2018 Apr; 24(4):329-333. PubMed ID: 29578854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.